Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

New approvals for Menorest

Nov. 28, 1997

Negative phase II results for long-term risedronate in osteoporosis

Nov. 28, 1997

Launch of Ligand/Lilly metabolic disease alliance

Nov. 27, 1997

Agents activating beta3-adrenoceptors from Pfizer

Nov. 27, 1997

Beaufour-Ipsen moves TH-9506 to phase I

Nov. 27, 1997

First marketing approval granted for Neumega

Nov. 26, 1997

PTK inhibitors for bone disorders from Novartis

Nov. 26, 1997

Roussel Uclaf discloses integrin antagonists for bone disorders

Nov. 26, 1997

ProLease hGH slated to enter phase III

Nov. 26, 1997

Sertoli and Carolinas Medical Center collaborate to develop novel diabetes therapy

Nov. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...